Ancora Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $389K | Hold |
3,622
| – | – | 0.01% | 574 |
|
2025
Q1 | $365K | Buy |
3,622
+450
| +14% | +$45.4K | 0.01% | 577 |
|
2024
Q4 | $283K | Sell |
3,172
-84
| -3% | -$7.5K | 0.01% | 627 |
|
2024
Q3 | $273K | Buy |
3,256
+10
| +0.3% | +$838 | 0.01% | 619 |
|
2024
Q2 | $250K | Hold |
3,246
| – | – | 0.01% | 604 |
|
2024
Q1 | $222K | Sell |
3,246
-119
| -4% | -$8.15K | 0.01% | 644 |
|
2023
Q4 | $195K | Buy |
3,365
+2,608
| +345% | +$151K | ﹤0.01% | 651 |
|
2023
Q3 | $40K | Hold |
757
| – | – | ﹤0.01% | 941 |
|
2023
Q2 | $41K | Buy |
757
+157
| +26% | +$8.5K | ﹤0.01% | 931 |
|
2023
Q1 | $30K | Sell |
600
-18
| -3% | -$901 | ﹤0.01% | 1002 |
|
2022
Q4 | $29K | Buy |
618
+18
| +3% | +$845 | ﹤0.01% | 1055 |
|
2022
Q3 | $23K | Hold |
600
| – | – | ﹤0.01% | 1259 |
|
2022
Q2 | $22K | Sell |
600
-409
| -41% | -$15K | ﹤0.01% | 1360 |
|
2022
Q1 | $45K | Buy |
1,009
+600
| +147% | +$26.8K | ﹤0.01% | 1274 |
|
2021
Q4 | $17K | Hold |
409
| – | – | ﹤0.01% | 1618 |
|
2021
Q3 | $18K | Buy |
+409
| New | +$18K | ﹤0.01% | 1481 |
|
2018
Q4 | – | Sell |
-220
| Closed | -$8K | – | 685 |
|
2018
Q3 | $8K | Buy |
+220
| New | +$8K | ﹤0.01% | 1213 |
|